Koyfin Home > Directory > Health Care > Horizon Therapeutics > Preferred Equity

Horizon Therapeutics Preferred Equity Chart (HZNP)

Horizon Therapeutics annual/quarterly Preferred Equity from 2010 to 2011.
  • Horizon Therapeutics Preferred Equity for the quarter ending June 06, 2011 was $0m a 0.00% decrease of 0m year over year
  • Horizon Therapeutics Preferred Equity for the last 12 months ending June 06, 2011 was $0m a 0.00% decrease of 0m year over year
Other Balance Sheet Metrics:
  • Horizon Therapeutics Total Assets for the quarter ending December 12, 2018 was $4,146m a 3.46% increase of 144m year over year
  • Horizon Therapeutics Other Liabilities for the quarter ending December 12, 2018 was $434m a -18.99% decrease of -82m year over year
  • Horizon Therapeutics Total Equity for the quarter ending December 12, 2018 was $1,054m a 18.31% increase of 193m year over year
View Chart On Koyfin

Quarterly HZNP Preferred Equity Data

06/2011$0m
12/2010$0m
09/2010$0m
06/2010$0m
03/2010$0m

Annual HZNP Preferred Equity Data

2010$0m